Remove Antibody Remove Genomics Remove Packaging Remove Sales
article thumbnail

IN FOCUS: Solvias

Pharmaceutical Technology

In regards to the latter, notable examples include the acquisition of Cergentis, a genomics-focused biotechnology company based in the Netherlands. The deal allows the company to provide proprietary technology and knowledge steeped in fast-evolving genomic techniques that support effective decision-making and R&D program design.

article thumbnail

Bristol Myers Squibb Reports Second Quarter 2020 Financial Results

The Pharma Data

NEW YORK–( BUSINESS WIRE )– Bristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2020, which reflect strong product sales, continued advancement of the pipeline and robust operating performance. chairman and chief executive officer, Bristol Myers Squibb. In May, the company announced the U.S.

article thumbnail

Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’

The Pharma Data

India approves Roche/Regeneron antibody cocktail to treat COVID-19 ( Reuters ). Adagio offers first peek at Covid-19 antibody data, with preventative numbers that may rival mRNA vaccines ( Endpoints ). FDA approves 100th monoclonal antibody product ( Nature Reviews Drug Discovery ).